Affiliation:
1. Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia
2. Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia
Abstract
Restriction endonucleases are a component of restriction–modification systems, where the main biological function is to protect bacterial cells from incoming foreign DNA molecules. There are four main types of restriction enzymes (types I, II, III, and IV), which differ in protein composition, cofactor requirements, and mode of action. The most studied are representatives of type II, which specifically recognize DNA sequences of 4–8 bp and catalyze DNA cleavage within these sequences or not far from them. The exceptional precision of type II enzymes has made them indispensable for DNA manipulations. Although hundreds of DNA restriction enzymes are currently known, there is still a need for enzymes that recognize new DNA targets. For this reason, the discovery of new natural restriction endonucleases and rational design of their properties (to obtain enzymes with high specificity for a unique nucleotide sequence at a restriction site and without nonspecific activity) will expand the list of enzymes for use in biotechnology and genetic engineering. This review briefly touches upon the main types of restriction endonucleases, their classification, nomenclature, and typical properties, and it concisely describes approaches to the construction of enzymes with altered properties.
Funder
Ministry of Science and Higher Education of the Russian Federation
Subject
Plant Science,Biochemistry, Genetics and Molecular Biology (miscellaneous),Food Science
Reference160 articles.
1. ZFN, TALEN, and CRISPR/Cas-Based Methods for Genome Engineering;Gaj;Trends Biotechnol.,2013
2. Cleavage of Viral DNA by Restriction Endonucleases Stimulates the Type II CRISPR-Cas Immune Response;Maguin;Mol. Cell,2022
3. Phan, H.T.L., Kim, K., Lee, H., and Seong, J.K. (2023). Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications. Genes, 14.
4. CRISPR/Cas9 Therapeutics: Progress and Prospects;Li;Signal Transduct. Target. Ther.,2023
5. Gene Editing and Crop Improvement Using CRISPR-Cas9 System;Arora;Front. Plant Sci.,2017